Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Nortriptyline NCT06799169 · Management of Acute Tinnitus With Migraine Medications | Migraine | À vérifier | Phase 4 | ACTIVE_NOT_RECRUITING | Tinnitus represents one of the most common and distressing otologic proble… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| PFOCUS — Neurogenetic And Hemodynamic Of Migraine Aura And Pfo NCT07349004 · NCT07349004 | Migraine | À vérifier | À vérifier | RECRUITING | The PFOCUS Study aims to clarify the relationship between patent foramen o… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) NCT07342296 · Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activa… | Migraine | À vérifier | Non applicable | NOT_YET_RECRUITING | Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) is a key… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Rimegepant NCT07667621 · A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acut… | Migraine | À vérifier | Phase 1 | NOT_YET_RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Rimegepant 75 MG NCT06409832 · RAISE — RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatme… | Migraine | Traitement symptomatique | À vérifier | RECRUITING | In a real-world population of adults with migraine, the investigators woul… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Rimegepant 75 MG Disintegrating Oral Tablet NCT05903027 · Gepant treAtments: EffectIveNess and tolERability (GAINER) | Migraine | À vérifier | À vérifier | RECRUITING | The purpose of this prospective and multicentric study is to evaluate the… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Rimegepant sulfate NCT07497854 · Rimegepant PMS — A Study to Learn About the Study Medicine NURTEC® ODT 75 mg Aft… | Migraine | À vérifier | À vérifier | NOT_YET_RECRUITING | The purpose of this study is to evaluate safety and effectiveness of NURTE… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| The Sequestration of Holistic Stress Management Techniques for Adults NCT06098755 · NCT06098755 | Migraine | À vérifier | Non applicable | WITHDRAWN | This remote study is intended to assist the population with access to cost… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Transcutaneous Electrical Nerve Stimulation (TENS) NCT07015125 · Evaluation of a Wearable Device for Acute Treatment of Migraines | Migraine | Traitement symptomatique | Non applicable | COMPLETED | The goal of this clinical trial is to determine the efficacy of a new, imp… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Ubrogepant NCT05127954 · UBRO PEDS OLE — Long-term Extension Study to Assess Safety and Tolerability of O… | Migraine | À vérifier | Phase 3 | ENROLLING_BY_INVITATION | Migraine is a common neurological disorder typically characterized by atta… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Understanding the Pathophysiology of Migraine Pain NCT03026101 · NCT03026101 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | TERMINATED | Migraine is the most common headache disorder, prevalent in 18% of females… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Atogepant 60 mg NCT04686136 · A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the… | Migraine | À vérifier | Phase 3 | COMPLETED | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| AURA — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENS… NCT07268768 · NCT07268768 | Migraine | Ralentissement de la progression · Traitement symptomatique | À vérifier | RECRUITING | Headache, in its episodic and chronic forms, cannot be considered solely a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| BOTOX NCT05028569 · Study of BOTOX Injections in Prevention of Migraine in Adult Participants With E… | Migraine | Thérapie génique | Phase 3 | TERMINATED | Migraine is a neurological disease characterized by moderate or severe hea… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| Cabergoline 0.5 MG NCT07072910 · PROTECT — Cabergoline for Episodic Migraine | Migraine | À vérifier | Phase 2 | RECRUITING | The goal of this randomized, placebo-controlled, double-blind clinical tri… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| Cerebri biofeedback NCT05616741 · BioCer — Home-based Biofeedback for the Prevention of Migraine | Migraine | À vérifier | Non applicable | COMPLETED | The goal of this clinical trial is to test an app-based biofeedback treatm… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| INMEST-treatment NCT07279623 · A-MI-01 — Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventativ… | Migraine | À vérifier | Non applicable | RECRUITING | This is a prospective, randomized, open-label, delayed-start clinical inve… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| Rimegepant NCT05207865 · Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Pr… | Migraine | À vérifier | Phase 4 | COMPLETED | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| Rimegepant 75mg daily dosing NCT05217927 · Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Mul… | Migraine | À vérifier | Phase 4 | COMPLETED | The purpose of this study is to compare the efficacy and safety of daily a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
| ViKEM — Vitamin K2 Supplementation in Adult Episodic Migraine NCT05943457 · NCT05943457 | Migraine | Ralentissement de la progression | Non applicable | RECRUITING | Migraine is a debilitating illness and a major cause of disability in the… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:11 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Agmatine and N-hydroxypipecolic acid synergistically enhance salt tol… Saline · PMID 42384575 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Salt stress severely limits wheat growth by disturbing photosynthesis, osmotic balance, and cellular redox homeostasis.… | Plant signaling & behavior 2026-08-16 13:04:04 | Source |
| Jasmonic acid and engineered dog manure biochar improve salinity tole… Saline · PMID 42517608 | Migraine | Neuroprotection | Publication | PubMed | Voir la publication source Salinity is a major abiotic stress that disrupts plant growth by altering hormone balance, oxidative homeostasis, and r… | Plant signaling & behavior 2026-08-16 13:04:04 | Source |
| Salinity signaling networks in wheat: crosstalk among Ca⁺, ROS, phyto… Saline · PMID 42423212 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Soil salinity limits wheat productivity by disrupting water uptake, Na⁺/K⁺ homeostasis, photosynthesis, reproductive de… | Plant signaling & behavior 2026-08-16 13:04:04 | Source |
| A prospective, randomized trial of intravenous prochlorperazine versu… Diphenhydramine IV · PMID 20045576 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Intravenous (IV) prochlorperazine with diphenhydramine is superior to subcutaneous sumatriptan in the treatment of migr… | Annals of emergency medicine 2026-08-16 13:02:34 | Source |
| Electroacupuncture for essential hypertension: Mechanistic insights,… Sham · PMID 42298753 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Essential hypertension (EH) remains a leading modifiable risk factor for cardiovascular morbidity and mortality worldwi… | Clinical and experimental hypertension (New York, N.Y.… 2026-08-16 13:01:56 | Source |
| Mailuo Shutong pills alleviate limb swelling in femoral fracture rats… Sham · PMID 42476204 | Migraine | Remyélinisation indirecte / réparation · Immunomodulation · Traitement symptoma… | Publication | PubMed | Voir la publication source Mailuo Shutong Pill (MLSTP) is a well-established formula developed by National Grand Master of Traditional Chinese Med… | Journal of ethnopharmacology 2026-08-16 13:01:56 | Source |
| Protective effects of polysaccharide on oxidative stress and liver in… Sham · PMID 42159294 | Migraine | Neuroprotection · Immunomodulation | Publication | PubMed | Voir la publication source Oxidative stress-induced liver injury can progress to severe hepatic conditions. Polysaccharides are promising therapeu… | Redox report : communications in free radical research 2026-08-16 13:01:56 | Source |
| Modelling post-traumatic stress disorder-major depressive disorder co… paroxetine · PMID 41920162 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Post-traumatic stress disorder comorbid with major depressive disorder (PTSD + MDD) is a multifactorial condition with… | European journal of psychotraumatology 2026-08-16 13:01:54 | Source |
| Psychopharmacological treatment of patients with heart failure: A nar… paroxetine · PMID 42259462 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Heart failure (HF) commonly coexists with psychiatric disorders, particularly depression and anxiety, which significant… | Current problems in cardiology 2026-08-16 13:01:54 | Source |
| Redox modulation contributes to the antidepressant-like and neuroprot… paroxetine · PMID 41697767 | Migraine | Neuroprotection · Immunomodulation | Publication | PubMed | Voir la publication source Alzheimer's disease (AD) is characterized by cognitive impairment and neuropsychiatric disturbances, including depressi… | Redox report : communications in free radical research 2026-08-16 13:01:54 | Source |
| The Impact of Multiple Sessions of Anodal Transcranial Direct Current… Sham Transcranial direct current stimulation · PMID 41130445 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This study aimed to assess the effects of anodal transcranial direct current stimulation (a-tDCS) of the primary motor… | Journal of aging and physical activity 2026-08-16 13:00:50 | Source |
| The oblique effect in visual working memory is enhanced by distractio… Sham Transcranial direct current stimulation · PMID 42014668 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source The sensory recruitment model suggests that visual working memory (VWM) relies on early visual cortex (EVC), while the… | Cognitive, affective & behavioral neuroscience 2026-08-16 13:00:50 | Source |
| Brain iron deposition mediates cognitive impairment in COPD: A possib… MRI · PMID 42464739 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Cognitive impairment is a relatively prevalent comorbidity in chronic obstructive pulmonary disease (COPD), yet its neu… | Pulmonology 2026-08-16 12:59:38 | Source |
| Extraperitoneal Single-Port Robotic-Assisted Radical Cystectomy with… MRI · PMID 42397987 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Radical cystectomy (RC) is the standard therapy for muscle-invasive bladder cancer (MIBC) and refractory high-risk non-… | International braz j urol : official journal of the Br… 2026-08-16 12:59:38 | Source |
| New pulse sequence for improving cardiac black-blood and PSIR MRI qua… MRI · PMID 42502572 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Most conventional cardiac MRI scans, which rely on electrocardiogram (ECG)-triggered segmented acquisition for k-space… | Magnetic resonance letters 2026-08-16 12:59:38 | Source |
| Docking Analysis of Drugs Used in the Treatment of Alzheimer's Diseas… Memantine · PMID 42589213 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Molecular docking in silico techniques were used to assess the interactions between several drugs used in the treatment… | International journal of molecular sciences 2026-08-13 15:07:26 | Source |
| Machine Perfusion in Liver Transplantation: A Systematic Review and M… SCS · PMID 42590059 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Static cold storage (SCS) remains the conventional standard for liver graft preservation; however, ischemia-reperfusion… | Journal of clinical medicine 2026-08-13 14:47:32 | Source |
| Measurement Invariance and Psychometric Properties of the Self-Concea… SCS · PMID 42588230 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Self-concealment is associated with greater psychological distress and decreased help-seeking engagement. This study ai… | Healthcare (Basel, Switzerland) 2026-08-13 14:47:32 | Source |
| Adjunctive middle meningeal artery embolization for chronic subdural… Middle Meningeal Artery embolization · PMID 42585760 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Randomized trials suggest that adjunctive middle meningeal artery embolization (MMAE) may reduce recurrence in chronic… | Clinical neurology and neurosurgery 2026-08-13 14:47:31 | Source |
| Beyond Middle Meningeal Artery: Paradoxical Predominance Sign Predict… Middle Meningeal Artery embolization · PMID 42586762 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Middle meningeal artery embolization (MMAE) is an emerging treatment for chronic subdural hematoma (CSDH). However, hem… | AJNR. American journal of neuroradiology 2026-08-13 14:47:31 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |